Audit 24101

FY End
2022-12-31
Total Expended
$5.03M
Findings
0
Programs
3
Year: 2022 Accepted: 2023-09-28
Auditor: Bonadio & CO LLP

Organization Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
CTV4U5BP4KM8 Michael Niekamp Auditee
9145883550 Michael Vollmer Auditor
No contacts on file

Notes to SEFA

Accounting Policies: The accompanying schedule of expenditures of federal awards (the schedule) includes thefederal award activity of American Thrombosis and Hemostasis Network, Inc. (ATHN) underprograms of the federal government for the year ended December 31, 2022 and has beenprepared in accordance with accounting principles generally accepted in the United States ofAmerica. The information in this schedule is presented in accordance with the requirements ofTitle 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, CostPrinciples, and Audit Requirements for Federal Awards (Uniform Guidance). Because theschedule presents only a selected portion of the operations of ATHN, it is not intended to anddoes not present the financial position, changes in net assets, or cash flows of ATHN. Expenditures reported on the schedule are reported on the accrual basis of accounting. Suchexpenditures are recognized following the cost principles contained in the Uniform Guidance,wherein certain types of expenditures are not allowable or are limited as to reimbursement.Amounts included in the schedule are actual expenditures for the year ended December 31,2022. Differences between amounts included in the schedule and amounts reported to fundingagencies for these programs result from report timing. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate.